These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29313713)

  • 41. Meta-Analysis Comparing P2Y
    Baldetti L; Melillo F; Moroni F; Gallone G; Pagnesi M; Venuti A; Beneduce A; Calvo F; Gramegna M; Godino C; D'Ascenzo F; De Ferrari GM; Capodanno D; Cappelletti AM
    Am J Cardiol; 2020 Jun; 125(12):1815-1822. PubMed ID: 32305225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety analysis of new P2Y12 inhibitors versus clopidogrel in patients with percutaneous coronary intervention: a meta-analysis.
    Gan XD; Wei BZ; Fang D; Fang Q; Li KY; Ding SL; Peng S; Wan J
    Curr Med Res Opin; 2015 Dec; 31(12):2313-23. PubMed ID: 26402735
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and Safety of Potent Oral P2Y
    Ma S; Li Z; Yu P; Song H; Jiang Z; Li Y; Han Y
    Cardiovasc Drugs Ther; 2020 Apr; 34(2):199-208. PubMed ID: 32006144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does thromboelastography predict bleeding in patients treated with clopidogrel or ticagrelor in off-pump coronary artery bypass grafting?
    Wang Z; Zou Y; Xia L; Li X; Yao Y; Ye Y; Lv Q
    Thromb Res; 2022 May; 213():145-153. PubMed ID: 35366436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perioperative Bleeding in Patients With Acute Coronary Syndrome Treated With Fondaparinux Versus Low-Molecular-Weight Heparin Before Coronary Artery Bypass Grafting.
    Khodabandeh S; Biancari F; Kinnunen EM; Mariscalco G; Airaksinen J; Gherli R; Gatti G; Demal T; Onorati F; Faggian G; De Feo M; Santarpino G; Rubino AS; Maselli D; Salsano A; Nicolini F; Zanobini M; Ruggieri VG; Bounader K; Perrotti A; Dalén M
    Am J Cardiol; 2019 Feb; 123(4):565-570. PubMed ID: 30527774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
    Chew DP; Huang Z; Pieper KS; White H; Mahaffey KW; Ferguson JJ; Califf RM; Aylward PG
    Am Heart J; 2008 Feb; 155(2):239-44. PubMed ID: 18215592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Recent advances on the studies of the platelet's inhibition and aggregation. State of the art of new P2Y12 antagonists].
    Cattaneo GJ; Podda GM; Cattaneo M
    Recenti Prog Med; 2011 Apr; 102(4):150-5. PubMed ID: 21572491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Timing of Oral P2Y
    Tarantini G; Mojoli M; Varbella F; Caporale R; Rigattieri S; Andò G; Cirillo P; Pierini S; Santarelli A; Sganzerla P; Cacciavillani L; Babuin L; De Cesare N; Limbruno U; Massoni A; Rognoni A; Pavan D; Belloni F; Cernetti C; Favero L; Saia F; Fovino LN; Masiero G; Roncon L; Gasparetto V; Ferlini M; Ronco F; Rossini R; Canova P; Trabattoni D; Russo A; Guiducci V; Penzo C; Tarantino F; Mauro C; Corrada E; Esposito G; Marchese A; Berti S; Martinato M; Azzolina D; Gregori D; Angiolillo DJ; Musumeci G; ;
    J Am Coll Cardiol; 2020 Nov; 76(21):2450-2459. PubMed ID: 32882390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Should clopidogrel be discontinued before coronary artery bypass grafting for patients with acute coronary syndrome? A systematic review and meta-analysis.
    Cao C; Indraratna P; Ang SC; Manganas C; Park J; Bannon PG; Yan TD
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):3092-8. PubMed ID: 24954178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequency and Reasons of Dual Antiplatelet Therapy Discontinuation and Switching of P2Y12 Inhibitors in Patients with Acute Coronary Syndrome Treated with Stent Implantation.
    Fuertes Ferre G; Caballero Jambrina I; Ruiz Aranjuelo A; Jimeno Sánchez J; Galache Osuna JG; Andrés Esteban EM; Casasnovas Lenguas JA; Diarte de Miguel JA
    Cardiology; 2019; 142(4):203-207. PubMed ID: 31266007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study.
    O'Connor SA; Amour J; Mercadier A; Martin R; Kerneis M; Abtan J; Brugier D; Silvain J; Barthélémy O; Leprince P; Montalescot G; Collet JP;
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002786. PubMed ID: 26553698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pretreatment With P2Y12 Inhibitors in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the Swedish Coronary Angiography and Angioplasty Registry.
    Jurga J; Szummer KE; Lewinter C; Mellbin L; Götberg M; Zwackman S; Nilsson J; Völz S; Erlinge D; Persson J; Omerovic E; Jernberg T; Venetsanos D
    Circ Cardiovasc Interv; 2021 Nov; 14(11):e010849. PubMed ID: 34592825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Outcomes of Ticagrelor in Korean Patients with Acute Myocardial Infarction without High Bleeding Risk.
    Park KH; Jeong MH; Kim HK; Ki YJ; Kim SS; Choi DH; Koh YY; Ahn Y; Kim HS; Gwon HC; Rha SW; Hwang JY;
    J Korean Med Sci; 2021 Nov; 36(42):e268. PubMed ID: 34725976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes.
    Montalescot G; Bolognese L; Dudek D; Goldstein P; Hamm C; Tanguay JF; ten Berg JM; Miller DL; Costigan TM; Goedicke J; Silvain J; Angioli P; Legutko J; Niethammer M; Motovska Z; Jakubowski JA; Cayla G; Visconti LO; Vicaut E; Widimsky P;
    N Engl J Med; 2013 Sep; 369(11):999-1010. PubMed ID: 23991622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI: A Meta-Analysis.
    Komosa A; Lesiak M; Krasiński Z; Grygier M; Siniawski A; Skorupski W; Olasińska-Wiśniewska A; Pyda M; Araszkiewicz A; Mitkowski P; Grajek S; Mularek-Kubzdela T; Hengstenberg C; Siller-Matula JM
    Thromb Haemost; 2019 Jun; 119(6):1000-1020. PubMed ID: 30919382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Initiation of and persistence with P2Y12 inhibitors in patients with myocardial infarction according to revascularization strategy: a nationwide study.
    Tajchman DH; Nabi H; Aslam M; Butt JH; Grove EL; Engstrøm T; Holmvang L; Fosbøl EL; Køber L; Sørensen R
    Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(7):774-786. PubMed ID: 34570197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ischemic and Bleeding Events Among Patients With Acute Coronary Syndrome Associated With Low-Dose Prasugrel vs Standard-Dose Clopidogrel Treatment.
    Shoji S; Sawano M; Sandhu AT; Heidenreich PA; Shiraishi Y; Ikemura N; Ueno K; Suzuki M; Numasawa Y; Fukuda K; Kohsaka S
    JAMA Netw Open; 2020 Apr; 3(4):e202004. PubMed ID: 32239221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry.
    Redfors B; Dworeck C; Haraldsson I; Angerås O; Odenstedt J; Ioanes D; Petursson P; Völz S; Albertsson P; Råmunddal T; Persson J; Koul S; Erlinge D; Omerovic E
    Eur Heart J; 2019 Apr; 40(15):1202-1210. PubMed ID: 30851037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST-Segment-Elevation Myocardial Infarctions.
    Schmucker J; Fach A; Mata Marin LA; Retzlaff T; Osteresch R; Kollhorst B; Hambrecht R; Pohlabeln H; Wienbergen H
    J Am Heart Assoc; 2019 Sep; 8(18):e012530. PubMed ID: 31538856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.
    Kohli P; Wallentin L; Reyes E; Horrow J; Husted S; Angiolillo DJ; Ardissino D; Maurer G; Morais J; Nicolau JC; Oto A; Storey RF; James SK; Cannon CP
    Circulation; 2013 Feb; 127(6):673-80. PubMed ID: 23277305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.